Our in vivo OI results demonstrated that NOX2 and MPO are the dominant sources of ROS during acute and chronic cutaneous DTHR, while iNOS-related RNS seems to have a rather minor contribution (Figure 1A). The gene discussed is NOS2; the disease is osteogenesis imperfecta.